Results 171 to 180 of about 174,911 (328)
In Yoo and Mainkar et al., we present a minimally invasive, CM‐selective modRNA delivery system encapsulated in lipid nanoparticles for intravenous (IV) administration. This platform enables selective cardiac translation of therapeutic modRNA but suppresses expression in off‐target tissues, including tumors.
Jimeen Yoo +19 more
wiley +1 more source
riboCIRC v2.0: an expanded resource for translatable CircRNAs. [PDF]
Xu Y, Yang L, Tang Y, Wang Y, Wang H.
europepmc +1 more source
Mammalogy Class 1994 Catalog - Michigan, New Mexico and Mexico
Lisa A Hollis
openalex +1 more source
PARPi Combining Nanoparticle LIN28B siRNA for the Management of Malignant Ascites
This study demonstrates that co‐inhibition of LIN28B and PARP using siLin28b/DSSP@lip‐PEG‐FA nanoparticles in combination with the PARP inhibitor BMN673 effectively suppresses the accumulation of malignant ascites associated with advanced cancers.
Yan Fang +13 more
wiley +1 more source
Editorial: In-depth interpretation of critical genomic information related to the biosynthesis of key specialized (secondary) metabolism in medicinal plants. [PDF]
Wang M, Guo X, Wang Z.
europepmc +1 more source
New Mexico, Wisconsin, Minnesota, Michigan, South Carolina, Missouri 1994 Catalog
Andrew Hawk
openalex +1 more source
CDK4/6 inhibition promotes CD8+ T cell expansion through tumor‐macrophage crosstalk by activating HIF‐1α and enhancing MIF‐CD44/CD74 signaling. This reprograms TAMs to boost MHC‐I antigen presentation, and CDK4/6 inhibitor‐trained M1 TAM supernatant therapy synergizes with low‐dose PD‐1 blockade to restore antitumor immunity.
Lin He +17 more
wiley +1 more source

